GLP-1 analogs are effective in treating type 2 diabetes and obesity, but the physiological functions and the pharmacological targets in the brain that mediate these important effects are not fully understood4. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.